The Biology and Genetics of CTLA4 Haploinsufficiency

To understand CTLA4 haploinsufficiency (CHAI), it is helpful to look at the microscopic world of your immune system. Your body relies on T cells to identify and destroy threats. However, these cells need constant management so they do not attack your own tissues. The CTLA-4 protein is one of several important immune checkpoints the body uses for this management ^[1][2].

The Biology of the ‘Brake’

The CTLA-4 protein is trafficked and expressed on specialized immune cells called Regulatory T cells (Tregs) and can be induced on activated conventional T cells. Its job is to find other cells, called Antigen-Presenting Cells (APCs), which are responsible for providing co-stimulation signals to the immune response ^[3].

A healthy immune system uses a process called transendocytosis to stay in balance by reducing co-stimulation ^[4]:

1. Binding: The CTLA-4 protein competes with CD28 to grab onto signaling molecules (called CD80 and CD86) on the surface of the APC ^[1].
2. Removal: Like a vacuum cleaner, the cell carrying CTLA-4 physically pulls these signaling molecules off the APC and brings them inside itself to be destroyed ^[4][5].
3. Silence: With fewer signaling molecules, the APC has reduced capacity to activate other “attacker” T cells. The immune response is effectively braked, but not completely switched off ^[4].

In CHAI, you have a mutation in one of your two CTLA4 genes. This means your cells cannot make enough functional CTLA-4 protein, or the protein doesn’t function correctly. Without enough “vacuums” to remove the signaling molecules, your immune system experiences excessive activation ^[6][7].

Genetics and Inheritance

CHAI follows an autosomal dominant inheritance pattern. This means that a person only needs to inherit one mutated copy of the gene from one parent to be at risk for the disease ^[8]. If a parent has the mutation, there is a 50% (1 in 2) chance of passing it to each child ^[9]. In some cases, the mutation is de novo, meaning it started with the patient and was not inherited from a parent ^[10].

However, having the gene does not always mean having the disease. This is due to two key genetic concepts:

• Incomplete Penetrance: Only about 67% to 71% of people with the mutation will ever develop clinical symptoms ^[8][11].
• Variable Expressivity: Even among family members with the exact same mutation, one person might have severe lung issues while another has only mild skin problems or low antibody levels ^[12][13].

Proving the Diagnosis

Because many immune diseases look alike, doctors combine clinical findings and specific tests to confirm that a pathogenic CTLA4 mutation is the true cause of your symptoms.

Differentiating Similar Conditions

Doctors must distinguish CHAI from “look-alike” conditions:

• LRBA Deficiency: This condition also results in low CTLA-4 levels, but it is recessive (you must inherit two mutated genes). In LRBA deficiency, the “vacuum” works, but the “recycling system” that moves CTLA-4 to the cell surface is broken ^[14][6].
• ALPS (Autoimmune Lymphoproliferative Syndrome): While ALPS also causes swollen lymph nodes and low blood counts, it is caused by a different problem: immune cells failing to “commit suicide” (apoptosis) when their job is done. CHAI is a failure of immune regulation, while ALPS is a failure to die ^[14].

Functional Assays

If genetic testing finds a Variant of Uncertain Significance (VUS)—a mutation where it isn’t clear if it’s harmful—doctors may use functional assays as supportive tests to see if the protein is working. However, a VUS requires formal genetics review and cannot be reclassified by a single test alone ^[7]:

• CTLA-4 Expression Test: Doctors use flow cytometry to count how much CTLA-4 is present on your Regulatory T cells. They often stimulate the cells in a lab to see if the level of CTLA-4 increases as it should ^[7][15].
• Transendocytosis Assay: In a specialized lab, scientists watch your T cells to see if they can successfully grab and remove the CD80/CD86 molecules from other cells. While this is a highly specialized supportive test, an abnormal result helps confirm the mechanism, but a normal one does not exclude all pathogenic mechanisms ^[7][16].

These tests are complex and are typically performed only at major academic immunology centers ^[17].